JSPR
Jasper Therapeutics·NASDAQ
--
--(--)
--
--(--)
JSPR fundamentals
Jasper Therapeutics (JSPR) released its earnings on Nov 10, 2025: revenue was 0 (YoY --), met estimates; EPS was -1.13 (YoY +8.87%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-1.13
+8.87%
Report date
Nov 10, 2025
EPS
Actual | -6.9 | -2.4 | -0.6 | -2.9 | -3.0359 | -3.6 | -1.6 | -1.5 | -1.6 | -1.5 | -1.03 | -0.97 | -1.24 | -1.62 | -1.41 | -1.74 | -1.13 |
Forecast | -3.0853 | -3.4364 | -3.5 | -3.1333 | -3.4 | -3.7402 | -1.6231 | -1.4847 | -1.552 | -1.6087 | -1.225 | -1.0886 | -1.0713 | -1.2542 | -1.3476 | -1.3263 | -1.2149 |
Surprise | -123.64% | +30.16% | +82.86% | +7.45% | +10.71% | +3.75% | +1.42% | -1.03% | -3.09% | +6.76% | +15.92% | +10.89% | -15.75% | -29.17% | -4.63% | -31.19% | +6.99% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Jasper Therapeutics's earnings call?What is Jasper Therapeutics's latest dividend and current dividend yield?Did Jasper Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Jasper Therapeutics year over year?What were the key takeaways from Jasper Therapeutics’s earnings call?What factors drove the changes in Jasper Therapeutics's revenue and profit?What does Jasper Therapeutics do and what are its main business segments?What is the market's earnings forecast for Jasper Therapeutics next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
